Riders · Special Provisions Relating to All Regulatory Agencies · Article VIII: Regulatory
Funding for the Prescription Monitoring Program
Rider 7 in the 2026-27 Act, page VIII-65
Through the session
- 2024-25 Act In current law rider 7
- Introduced (Senate) Amended rider 7
- Introduced (House) Amended rider 7
- Senate substitute Amended rider 7
- House substitute Unchanged rider 7
- House passed Unchanged rider 7
- Conference Unchanged rider 7
- 2026-27 Act Unchanged rider 7
Pick any two steps to compare their wording.
What changed in the text
Introduced (Senate) → Senate substitute: 1 passage changed.
Removed words are struck through; added words are underlined. Sources: Introduced (Senate) · Senate substitute.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 7 | First version | — | Page VIII-61 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | 7 | Amended | — | Page VIII-64 |
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | 7 | Amended | — | Page VIII-64 |
| Senate substituteCommittee Substitute for Senate Bill 1 | 7 | Amended | Updated years only | Page VIII-59 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 7 | Unchanged | Updated years only | Page VIII-59 |
| House passedSenate Bill 1 as passed the second house | 7 | Unchanged | Updated years only | Page VIII-59 |
| ConferenceConference Committee Report for Senate Bill 1 | 7 | Unchanged | Updated years only | Page VIII-64 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 7 | Unchanged | Updated years only | Page VIII-65 |
Full text of each wording
Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page VIII-65Funding for the Prescription Monitoring Program.
(a) Each Article VIII licensing agency participating in the Prescription Monitoring Program is authorized in accordance with Sec. 554.006 of the Occupations Code to assess a fee on licensees by an amount sufficient to cover the cost of the Prescription Monitoring Program administered by the Board of Pharmacy.
(b) The following is an informational listing of fee revenue for each Article VIII licensing agency participating in the Prescription Monitoring Program for the purpose of paying for the Prescription Monitoring Program.
2026 2027
Texas Medical Board $ 715,848 $ 723,452
Optometry Board 21,776 21,802
Texas State Board of Dental Examiners 119,792 117,570
Texas State Board of Nursing 225,267 227,230
Board of Veterinary Medical Examiners 127,651 125,284
Texas Department of Licensing and Regulation 8,397 8,242
Board of Pharmacy 301,107 296,259
Total $1,519,838 $1,519,838
(c) The fee revenue collected by each participating agency shall be transferred to the Board of Pharmacy, responsible for administering the appropriate provisions of Chapter 481 of the Health and Safety Code. In the event that the actual and/or projected revenue collections from monitoring fees to cover the cost of the program are insufficient to offset the costs identified above, the Comptroller is hereby directed to reduce the appropriation authority provided by this Act to the Board of Pharmacy to be within the amount of fee revenue expected to be available.
Introduced (Senate), Introduced (House)
Source, page VIII-64Funding for the Prescription Monitoring Program.
(a) Each Article VIII licensing agency participating in the Prescription Monitoring Program is authorized in accordance with Sec. 554.006 of the Occupations Code to assess a fee on licensees by an amount sufficient to cover the cost of the Prescription Monitoring Program administered by the Board of Pharmacy.
(b) The following is an informational listing of fee revenue for each Article VIII licensing agency participating in the Prescription Monitoring Program for the purpose of paying for the Prescription Monitoring Program.
2026 2027
Texas Medical Board $ 715,848 $ 723,452
Optometry Board 21,776 21,802
Texas State Board of Dental Examiners 119,792 117,570
Texas State Board of Nursing 225,267 227,230
Board of Veterinary Medical Examiners 127,651 125,284
Texas Department of Licensing and Regulation 8,397 8,242
Board of Pharmacy 301,107 296,259
Total $1,519,838 $1,519,838
(c) The fee revenue collected by each participating agency shall be transferred to the Board of Pharmacy, responsible for administering the appropriate provisions of Chapter 481 of the Health and Safety Code. In the event that the actual and/or projected revenue collections from monitoring fees to cover the cost of the program are insufficient to offset the costs identified above, the Comptroller is hereby directed to reduce the appropriation authority provided by this Act to the Board of Pharmacy to be within the amount of fee revenue expected to be available. Eighty-eighth Legislature Salary Increases for Article VIII Agencies.
(a) Amounts appropriated elsewhere in this Act include the following amounts from the following sources which are to be used to maintain agencies' salary increases effective September 1, 2023 as described by this section:
(1) Behavioral Health Executive Council, $794,796 from the general revenue fund;
(2) Board of Chiropractic Examiners, $134,220 from the general revenue fund;
(3) Texas State Board of Dental Examiners, $673,000 from the general revenue fund;
(4) Funeral Services Commission, $147,976 from the general revenue fund;
(5) Board of Professional Geoscientists, $57,862 from the general revenue fund;
(6) Office of Public Insurance Counsel, $174,494 from the general revenue fund;
(7) Department of Licensing and Regulation, $7,176,044 from the general revenue fund;
(8) Texas Medical Board, $2,699,316 from the general revenue fund;
(9) Texas Board of Nursing, $1,801,616 from the general revenue fund;
(10) Optometry Board, $64,084 from the general revenue fund;
(11) Board of Pharmacy, $1,419,559 from the general revenue fund;
(12) Executive Council of Physical Therapy & Occupational Therapy Examiners, $239,392
from the general revenue fund;
(13) Board of Plumbing Examiners, $515,516 from the general revenue fund;
(14) Racing Commission, $492,186 from General Revenue-Dedicated Texas Racing Commission Account No. 597;
(15) Securities Board, $1,315,932 from the general revenue fund; and
(16) Board of Veterinary Medical Examiners, $301,212 from the general revenue fund.
(b) A state agency that receives appropriations of money described under Subsection (a) may not increase fees or taxes to offset the appropriation. For the state agencies identified under Subsection (a) that are subject to a provision limiting the amount appropriated to the agency to revenues collected by the agency, the amount necessary to provide employees the specified agencies salary increase is included in the amount identified under Subsection (a).
2024-25 Act
Source, page VIII-61Funding for the Prescription Monitoring Program.
(a) Each Article VIII licensing agency participating in the Prescription Monitoring Program is authorized in accordance with Sec. 554.006 of the Occupations Code to assess a fee on licensees by an amount sufficient to cover the cost of the Prescription Monitoring Program administered by the Board of Pharmacy.
(b) The following is an informational listing of fee revenue for each Article VIII licensing agency participating in the Prescription Monitoring Program for the purpose of paying for the Prescription Monitoring Program.
2024 2025
Texas Medical Board $ 715,848 $ 723,452
Optometry Board 21,776 21,802
Texas State Board of Dental Examiners 119,792 117,570
Texas State Board of Nursing 225,267 227,230
Board of Veterinary Medical Examiners 127,651 125,284
Texas Department of Licensing and Regulation 8,397 8,242
Board of Pharmacy 301,107 296,259
Total $1,519,838 $1,519,838
(c) The fee revenue collected by each participating agency shall be transferred to the Board of Pharmacy, responsible for administering the appropriate provisions of Chapter 481 of the Health and Safety Code. In the event that the actual and/or projected revenue collections from monitoring fees to cover the cost of the program are insufficient to offset the costs identified above, the Comptroller is hereby directed to reduce the appropriation authority provided by this Act to the Board of Pharmacy to be within the amount of fee revenue expected to be available.